| 摘要 |
Production of a solid dosage form (A) involves: (1) forming a shapable mass comprising (by weight) 50-99.4% crosslinked, non-thermoplastic carrier (I), 0.5-30 wt. % adjuvant(s) (II) selected from thermoplastic polymers, lipids, sugar alcohols (or derivatives) and solubilizers and 0.1-49.5% active agent(s) (III) at or above the softening point of (II) (but at 70 degrees C or more); and (2) cooling. |
